13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 2 managers

Reported value

$453K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$21.5K

Price effect on 1 books still in the name

Largest holder

$273K

Swiss Life Asset Management Ltd

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Swiss Life Asset Management Ltd1.87K$273KNew
Leonteq Securities AG1.23K$180K−$21.5KCut−$61.5K

Positions as of Q2 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.